Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate whether planned transition between 90 and 150 days post-transplantation to SRL-based therapy from TAC-based therapy is associated with a clinically relevant degree of improvement in renal function (≥ 5.0 mL/min/1.73 m2) compared to continuation of TAC-based therapy.
Critère d'inclusion
- Renal function in kidney transplant